Particle.news

Download on the App Store

ECDC Flags Rapid Spread of Drug-Resistant Candidozyma auris in European Hospitals

ECDC urges tighter hospital controls to counter rising institutional risk from surveillance gaps, antifungal resistance.

Overview

  • A new ECDC analysis counts 4,012 European cases of C. auris from 2013 to 2023, including 1,346 in 2023, with several countries now reporting in-hospital transmission.
  • Germany reported 120 infections over the decade, 77 in 2023, placing it among the five European countries with the most recorded cases.
  • The fungus persists on skin, surfaces and medical devices and spreads via contact or contaminated equipment, not through the air.
  • Many strains resist widely used antifungals such as fluconazole, limiting treatment options and complicating outbreak management.
  • Germany has required reporting of invasive detections since July 2023, yet experts warn that surveillance undercounts true spread and that containment measures can only slow dissemination.